Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc., trading under the ticker HSAQ, is a healthcare and medical technology focused special purpose acquisition company that completed its IPO in 2021. The vehicle filed an amended quarterly report, Form 10-Q/A, with the SEC on March 31, 2022, bearing accession number 0001213900-22-016917, reflecting updated disclosures for the applicable reporting period. Orchestra BioMed, the target operating company, is a medical device firm developing therapies in cardiac rhythm management and hypertension. The SPAC targeted the life sciences and medtech sector in its search for a combination partner. Visit SpacDesk and sign up for full access to HSAQ's filing history, merger timeline, and comparable deal analytics.